| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| inolimomab | interleukin-2 receptor subunit alpha | biotech | NA | drugbank , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Heart[MeSHID:D006321] Graft Rejection[MeSHID:D006084] |
4.39 | investigational | antibody |
| inolimomab | interleukin 2 receptor alpha | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Heart[MeSHID:D006321] Graft Rejection[MeSHID:D006084] |
4.39 | phase 3 | unknown |
| inolimomab | interleukin-2 receptor subunit alpha | biotech | NA | drugbank , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Heart[MeSHID:D006321] Graft Rejection[MeSHID:D006084] |
4.39 | investigational | antibody,antagonist |
| inolimomab | interleukin 2 receptor alpha | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Heart[MeSHID:D006321] Graft Rejection[MeSHID:D006084] |
4.39 | phase 3 | antagonist |
| click here to return to the previous page | ||||||||